Pancreatic Cancer Research

ResearcherUniversidade do PortoNo recent work listed

Manuel A. N. Coelho

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7312-3429; OpenAlex author ID A5011524809. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper

Papers 5

  1. Doxorubicin and Varlitinib Delivery by Functionalized Gold Nanoparticles Against Human Pancreatic Adenocarcinoma. Last author DOI 10.3390/pharmaceutics11110551↗
  2. Gold Nanoparticles for Targeting Varlitinib to Human Pancreatic Cancer Cells. Last author DOI 10.3390/pharmaceutics10030091↗
  3. Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer. Co-author DOI 10.3390/pharmaceutics10040216↗
  4. Enhancing the efficiency of bortezomib conjugated to pegylated gold nanoparticles: an in vitro study on human pancreatic cancer cells and adenocarcinoma human … Last author DOI 10.1080/17425247.2016.1178234↗
  5. Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells. Last author DOI 10.1002/jbm.a.35286↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sílvia Castro Coelho · 4 shared papers, 2016–2019 · strength 0.40
  2. Ana Santos-Rebelo · 1 shared paper, 2018 · strength 0.07
  3. Catarina Pinto Reis · 1 shared paper, 2018 · strength 0.07
  4. Manuela F. Frasco · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.